openPR Logo
Press release

Antimycobacterial Drugs Market : Emerging Trends, Business Growth Opportunities, Major Driving Factors

02-04-2020 01:08 PM CET | Health & Medicine

Press release from: Transparency Market Research

Antimycobacterial Drugs Market : Emerging Trends, Business

Antimycobacterial drugs are used to treat infections caused by members of Mycobacterium genus. Mycobacterium genus includes M. tuberculosis, M. leprae, and M. avium-intracellulare which cause tuberculosis, leprosy, and atypical mycobacteria, respectively. Tuberculosis and leprosy are the most common infections caused by mycobacteria genus. M. avium-intracellulare bacteria are usually present in water and soil and are less harmful to humans compared to M. tuberculosis. Therefore, infections caused by these bacteria are called atypical and non-tuberculous infections.

Report Overview @ http://www.transparencymarketresearch.com/antimycobacterial-drugs-market.html

Infections caused by mycobacteria are treatable, but usually require more than one medicine due to the tendency of bacteria to develop resistance to drugs. Increase in government initiatives for the treatment of TB, rise in prevalence of mycobacterial diseases such as tuberculosis and leprosy, surge in awareness about infections, favorable reimbursement policies, and resistance developed by bacteria for antimycobacterial drugs are the major factors expected to drive the global antimycobacterial drugs market.

However, low availability of proper diagnostic facilities for diseases such as leprosy is likely to restrain the market. Development of novel drug delivery systems affecting bacterial resistance and reducing the amount of drugs required for the complete treatment of infection are the recent trends in the global antimycobacterial drugs market.

The global antimycobacterial drugs market can be segmented based on product type and distribution channel. In terms of product type, the antimycobacterial drugs market can be classified into drugs used for tuberculosis, drugs used for leprosy, and drugs used for atypical mycobacteria. The drugs used for tuberculosis segment can be bifurcated into first line drugs and alternative drugs. First line drugs include isoniazid, ethambutol, streptomycin, and rifampicin. Alternative drugs include PAS (para amino salicylate) and ethionamide.

Get a Glimpse of the In-Depth Analysis through our Comprehensive "Antimycobacterial Drugs Market" Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52050

The drugs used for leprosy segment includes Dapsone (diamino diphenyl sulfone), clofazimine, and rifampicin. Atypical mycobacteria drugs include azithromycin and clarithromycin. The drugs used for tuberculosis segment held the largest share of the antimycobacterial drugs market in 2017 due to campaigns organized by governments to spread awareness about tuberculosis. The segment is expected to sustain its leadership position during the forecast period.

Based on distribution channel, the global antimycobacterial drugs market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment dominated the antimycobacterial drugs market in 2017 due to easy availability of leprosy and tuberculosis medications in government hospitals. The segment is expected to continue to dominate the market from 2018 to 2026.

In terms of region, the global antimycobacterial drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Middle East & Africa dominated the global market in 2017 due to high prevalence of TB and related co-infections in the developing countries. According to WHO, in 2017, 10 million people were infected with TB in the region, and 1.6 million succumbed to the disease (including 0.3 million with HIV). The market in Asia Pacific is anticipated to expand at the highest CAGR owing to rise in prevalence of mycobacterial diseases, surge in awareness, increase in per capita income, and improvement in health care infrastructure.

Pre Book "Antimycobacterial Drugs Market" Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=52050<ype=S

Major players operating in the global antimycobacterial drugs market include Bayer AG, GlaxoSmithKline plc, Lupin Limited, Pfizer, Inc., Macleods Pharmaceuticals, Novartis AG, Systopic Laboratories Pvt. Ltd., AstraZeneca plc, Sanofi, Zydus Cadila, and Merck & Co., Inc.

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antimycobacterial Drugs Market : Emerging Trends, Business Growth Opportunities, Major Driving Factors here

News-ID: 1918552 • Views: 219

More Releases from Transparency Market Research

Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the

All 5 Releases


More Releases for Antimycobacterial

Home Infusion Therapy Market Size, Share | Industry Report 2026
The global Home Infusion Therapy Market was valued at $14.2billion in 2018 and is forecast to grow at a modestxx.3 % CAGR between 2018 and 2026, culminating in 2026 global sales of $28.8 billion. Home Infusion Therapy has been demonstrated as a convenient, cost-effective way to administer therapy for many conditions are there, however, depending on a patient’s condition and therapy, home infusion must be assessed to determine if that
Global Antimycobacterial Drugs Market Size, Status, Market Growth, Application, …
Currently, the Antimycobacterial Drugs is innovating itself due to the growing market trends and stiff competition in the global market. Recently, a fresh report focusing on the “Global Antimycobacterial Drugs Market Size, Status and Forecast 2018-2025" has been broadcasted to the huge database of Market Research Hub (MRH), which aims to present a decisive analysis of the major facts such as drivers, restraints and opportunities present for the active as